MTI announces new state-of-the-art clinical space with DynaLIFE Accelerator Lab
Edmonton, Alberta, May 27, 2019 - DynaLIFE and Metabolomic Technologies Inc. (MTI) today unveiled a new state-of-the art clinical space in Edmonton enabling the assessment of an innovative new test for Albertans in the detection and prevention of colorectal cancer, the second most commonly diagnosed cancer in Canada and the second and third leading cause of cancer-related deaths for men and women.
“Over the last few months, DynaLIFE has been working closely with MTI and their flagship product, PolypDx™ with the aim to provide doctors with this exceptional new tool for early screening and detection enabling the timely removal of polyps before they progress to colorectal cancer,” says Jason Pincock, Chief Executive Officer of DynaLIFE. “Partnering with MTI was a natural fit for DynaLIFE as we immediately recognized the value of incorporating this innovative diagnostic technology.”
See the full news release here.